Product Information
GNP URINARY PAIN RLF 99.5 MG is a generic product labeled by AmerisourceBergen, priced at $0.1840 per EA under NDC 46122062862. Its NADAC has been published 83 times since Mar 5, 2025.
Strength
99.5 mg/1
Manufacturer
AmerisourceBergenNDC
46122062862
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENAZOPYRIDINE HYDROCHLORIDEApproval Type
Unapproved
On Market Since
7/2/2020
Price Statistics
The NADAC for GNP URINARY PAIN RLF 99.5 MG has been published 83 times since Mar 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1840 per EA |
|---|---|
| All-time high | $0.1971 (Apr 15, 2026) |
| All-time low | $0.1730 (Sep 17, 2025) |
| 52-week high | $0.1971 |
| 52-week low | $0.1730 |
| Median price | $0.1826 |
| Average price | $0.1825 |
| Largest weekly change | +4.6% (Feb 18, 2026) |
| Weeks tracked | 83 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PHENAZOPYRIDINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP URINARY PAIN RLF 99.5 MG?
The current National Average Drug Acquisition Cost (NADAC) for GNP URINARY PAIN RLF 99.5 MG, manufactured by AmerisourceBergen, is $0.1840 per EA (NDC 46122062862), effective Sep 30, 2026.
How has the price of GNP URINARY PAIN RLF 99.5 MG changed over time?
Over the history we have for it, the NADAC for GNP URINARY PAIN RLF 99.5 MG has held within roughly two percent of its current level. It has been tracked across 83 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for GNP URINARY PAIN RLF 99.5 MG?
Since Mar 5, 2025, the NADAC for GNP URINARY PAIN RLF 99.5 MG has ranged from a low of $0.1730 (Sep 17, 2025) to a high of $0.1971 (Apr 15, 2026), with a median of $0.1826 per EA.
Are there cheaper alternatives to GNP URINARY PAIN RLF 99.5 MG?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SM URINARY PAIN RLF 99.5 MG TB, is $0.1730 per EA — about 6% below GNP URINARY PAIN RLF 99.5 MG.
Who manufactures GNP URINARY PAIN RLF 99.5 MG?
GNP URINARY PAIN RLF 99.5 MG (NDC 46122062862) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.